You are here

Amgen

ESMO: Amgen's Lumakras confirmatory lung cancer data are here, fanning KRAS battle flames

Fierce Pharma

Sun, 09/11/22 - 11:07 pm

KRAS inhibitors

Could This Biosimilar Drug Candidate Be a Winner for Amgen?

Motley Fool

Fri, 09/9/22 - 10:57 am

Amgen's Neulasta gains another biosimilar competitor as sales slip

Endpoints

Thu, 09/8/22 - 04:35 pm

Amgen’s Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod

MedCity News

Wed, 08/31/22 - 10:23 am

non-small cell lung cancer

clinical trials

Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe

Fierce Pharma

Fri, 08/12/22 - 10:17 am

Plaque psoriasis and psoriatic arthritis: trials to watch in 2022

Clinical Trials Arena

Tue, 08/9/22 - 06:32 am

clinical trials

psoriatic arthritis

World Lung – Toxicity scuppers Amgen’s first-line lung hopes

EP Vantage

Mon, 08/8/22 - 09:53 am

non-small cell lung cancer

Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition

Fierce Biotech

Fri, 08/5/22 - 10:42 am

Multiple Myeloma

bispecific antibodies

Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence

Fierce Pharma

Thu, 08/4/22 - 12:10 pm

Weeks after starting, Amgen flashes yellow light on PhIII of $400M eczema bet

Endpoints

Thu, 08/4/22 - 11:03 am

clinical trials

atopic dermatitis

Drugmakers leap back into fading heart drug market

Beckers Hospital Review

Thu, 07/28/22 - 06:40 pm

Bristol Myers Squibb

Alnylam Pharmaceuticals

Big Pharmas Amgen, BMS shield BigHat from stormy market with $75M funding

Fierce Biotech

Wed, 07/20/22 - 10:01 am

BigHat Biosciences

Bristol Myers Squibb

Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents

Endpoints

Tue, 07/19/22 - 10:01 pm

Amgen's blockbuster hopeful Lumakras sees slower than expected sales in latest data, analyst says

Endpoints

Mon, 07/11/22 - 05:53 pm

non-small cell lung cancer

Amgen-backed Kernal Biologics pops off with $25M for mRNA platform

Fierce Biotech

Thu, 07/7/22 - 06:22 pm

Kernal Biologics

Amgen sells its Turkish manufacturing arm for $135M

Endpoints

Wed, 06/29/22 - 05:35 pm

drug manufacturing

Amgen takes next step with its China ambitions, out-licensing drugs to Fosun Pharma

Endpoints

Mon, 06/27/22 - 06:58 pm

Fosun Pharmaceutical

As biosimilars gain steam, Amgen exec lays out its Humira copycat plans

Fierce Pharma

Wed, 06/22/22 - 06:57 pm

Cytokinetics aims to become the Vertex of cardiovascular disease

EP Vantage

Thu, 06/16/22 - 10:19 am

Omecamtiv Mecarbil

cardiovascular disease

ASCO 2022 – the spirit of Rova-T struggles to live on

EP Vantage

Tue, 06/7/22 - 10:19 am

Harpoon Therapeutics

Boehringer Ingelheim

Pages